Live Breaking News & Updates on Atopic Dermatitis Disease Landscape

Stay updated with breaking news from Atopic dermatitis disease landscape. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ASLAN Pharmaceuticals Enters Into a Strategic Licensing Deal With Zenyaku Kogyo for the Development and Commercialization of Eblasakimab in Japan

ASLAN will receive up to $15 million in upfront and near-term payments and up to an additional $123.5 million based on development and commercial milestones plus tiered royalties on sales in percentages ranging up to low twentiesZenyaku Kogyo, a leading J. ....

United States , Ashleyr Robinson , Carl Firth , Koichi Hashimoto , Emma Thompson , Zenyaku Kogyo , Chugai Pharmaceutical Co Ltd , Pharmaceuticals Nasdaq , Decision Resources Group , Globenewswire Inc , Zenyaku Kogyo Co Ltd , Zenyaku Holdings Co Ltd , Zenyaku Holdings , Company Annual Report On Form , Commission File No , Spurwing Communications , Exchange Commission , Lifesci Advisors , Chief Executive Officer , B Cell Non Hodgkin , Commission File , Annual Report , Resources Group , Atopic Dermatitis Disease Landscape , Sci Advisors ,